GlassScriptPhysician profile
Thomas William Petrusick
NPI 1942266788
$1,104.07
in general payments reported to CMS, 2019-2025
17 companies · $157 in 2025
The $157 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $108 · 2021: $188 · 2022: $162 · 2023: $106 · 2024: $254 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $308.42 | 2021-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $164.87 | 2019-2024 | |
| Glaxosmithkline, LLC. | $82.28 | 2019-2021 | |
| Corium, LLC | $77.76 | 2021-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $64.29 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $57.36 | 2021-2025 | Gardasil 9, M-M-R II, Gardasil |
| Collegium Pharmaceutical, INC. | $51.56 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $49.84 | 2023-2025 | |
| Sanofi Pasteur INC. | $43.18 | 2019-2023 | |
| Ultragenyx Pharmaceutical INC. | $38.32 | 2021-2023 | |
| Sobi, INC | $35.18 | 2019-2021 | |
| Neos Therapeutics, LP | $30.62 | 2020-2023 | Cotempla Xr-Odt |
| Shire North American Group INC | $26.46 | 2019 | |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $21.73 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.97 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.03 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $14.20 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Petrusick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.